Here’s What $1,000 Invested in Vaccine Stocks Would Be Worth Now
It’s often said that with every crisis comes great opportunity.
While such catastrophes do create upheaval and uncertainty in financial markets, they can also lead to new opportunities for investors, as asset classes react to different environments.
Since the World Health Organization (WHO) declared COVID-19 to be a pandemic on March 11, 2020, the performance of vaccine stocks have been varied—but with some notable winners that notched triple or quadruple digit returns.
First published: April 18, 2021 (link)
Source files included: .ai, .eps, .pdf
Data source: S&P Global Market Intelligence
A full license grants you the permission to download and modify our visualization, and to re-publish it in most professional and personal use cases.
Licenses also give you permission to translate our visualizations into another language, provided that you also remove the Visual Capitalist branding.
Type of License | Full License (1 Credit) |
---|